date:Oct 12, 2017
the potential for growth of pathogenic bacteria. The defendants allegedly also did not monitor sanitation conditions and practices to make sure they were in conformance with current good manufacturing practices. They also supposedly failed to take corrective action that made sure that the product was not introduced into commerce.
Melinda K. Plaisier, FDA Associate Commissioner for Regulatory Affairs said in a statement, When we find contaminants that can harm public health at a food manufacturi